BioSpace News Archive

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven”) announced today that NURTEC® ODT (rimegepant) was approved by the Kuwait Ministry of Health for the acute treatment of migraine with and without aura in adults.

Memgen, Inc., a clinical-stage biotechnology company developing potentially life-saving cancer immunotherapies, announced that Kevin M. Coveney, CPA, has been appointed Chief Financial Officer.

Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announces the appointment of Matt Posard to their Board of Directors.

Greenwich LifeSciences, Inc. announced CEO Snehal Patel will participate in the virtual portion of Jefferies’ Annual London Healthcare Conference held from November 16-19, 2021.

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that new Phase 3 data for molnupiravir, an investigational oral COVID-19 antiviral medicine, will be presented as a late-breaking poster at the American Society of Tropical Medicine and Hygiene 2021 Annual Meeting taking place virtually from Nov. 17-21.

ANGLE plc, a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 22,667 new ordinary shares of £0.10 each in the Company.

Eloxx Pharmaceuticals, Inc. today announced positive topline results from the monotherapy arms of its Phase 2 clinical trial of ELX-02 in Class 1 cystic fibrosis (CF) patients with at least one G542X nonsense allele mutation.

Prilenia Therapeutics B.V. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pridopidine for development as a potential treatment for Huntington’s Disease (HD).

Biogen Inc. and Eisai Co., Ltd. announced an update on the ongoing review of the Marketing Authorization Application for aducanumab 100 mg/mL concentrate solution for infusion for the treatment of Alzheimer’s disease by the Committee for Medicinal Products for Human Use of the European Medicines Agency.

Conference call and webcast today, November 17, 2021, 9:00 am ET to provide its financial results.